Trends and correlates in HIV viral load monitoring and viral suppression among adolescents and young adults in Dar es Salaam, Tanzania.
ART
HIV viral load monitoring
Tanzania
adolescents and young adults
viral suppression
Journal
Tropical medicine & international health : TM & IH
ISSN: 1365-3156
Titre abrégé: Trop Med Int Health
Pays: England
ID NLM: 9610576
Informations de publication
Date de publication:
04 Aug 2024
04 Aug 2024
Historique:
medline:
5
8
2024
pubmed:
5
8
2024
entrez:
4
8
2024
Statut:
aheadofprint
Résumé
Adolescents and young adults (AYA) living with HIV have been shown to have lower rates of viral load testing and viral suppression as compared to older adults. We examined trends over time and predictors of HIV viral load monitoring and viral suppression among AYA in a large HIV treatment programme in Dar es Salaam, Tanzania. We analysed longitudinal data of AYA aged 10-24 years initiated on antiretroviral therapy between January 2017 and October 2022. Trend models were used to assess changes in HIV viral load testing and viral suppression by calendar year. Generalised estimating equations were used to examine the relationship of sociodemographic and clinical factors with HIV viral load testing and viral suppression. Out of 15,759 AYA, the percentage of those who received a 6-month HIV viral load testing increased from 40.6% in 2017 to 64.7% in 2022 and, a notable annual increase of 5.6% (p < 0.001). A higher HIV viral load testing uptake was observed among 20- to 24-year-olds (87.7%) compared to 10- to 19-year-olds (80.2%) (p < 0.001). The likelihood of not receiving an HIV viral load test within 12 months of antiretroviral therapy initiation was higher among 10- to 19-year-olds (adjusted odds ratio [aOR] = 1.7; 95% confidence interval [CI] = 1.4-2.0), advanced HIV disease (aOR = 1.3; 95% CI = 1.12-1.53), normal nutrition status at enrolment aOR 2.6 (95% CI = 1.59-4.26) and initiation of non-nucleoside reverse transcriptase inhibitors regimen aOR 1.2 (95% CI = 1.08-1.34). The proportion of AYA with viral suppression increased from 83.0% in 2017 to 94.6% in 2022. Notably, the overall trend in viral suppression increased significantly at 2.4% annually. The risk of not achieving viral suppression was greater among 10- to 14-year-olds (aOR = 2; 95% CI = 1.75-2.43) and 15- to 19-year-olds (aOR = 1.4; 95% CI = 1.24-1.58) as compared to 20-24 years; being male (aOR = 1.16; 95% CI = 1.02-1.32); undernourished (aOR = 1.53; 95% CI = 1.17-1.99); in WHO Stage II (aOR = 1.16; 95% CI = 1.02-1.33) and III (aOR = 1.21; 95% CI = 1.03-1.42) and being on an non-nucleoside reverse transcriptase inhibitors regimen (aOR = 1.32; 95% CI = 1.18-1.48). HIV viral load testing uptake at 6 months of antiretroviral therapy initiation and viral suppression increased from 2017 to 2022; however, overall HIV viral load testing was suboptimal. Demographic and clinical characteristics can be used to identify AYA at greater risk for not having HIV viral load test and not achieving viral suppression.
Sections du résumé
BACKGROUND
BACKGROUND
Adolescents and young adults (AYA) living with HIV have been shown to have lower rates of viral load testing and viral suppression as compared to older adults. We examined trends over time and predictors of HIV viral load monitoring and viral suppression among AYA in a large HIV treatment programme in Dar es Salaam, Tanzania.
METHODS
METHODS
We analysed longitudinal data of AYA aged 10-24 years initiated on antiretroviral therapy between January 2017 and October 2022. Trend models were used to assess changes in HIV viral load testing and viral suppression by calendar year. Generalised estimating equations were used to examine the relationship of sociodemographic and clinical factors with HIV viral load testing and viral suppression.
RESULTS
RESULTS
Out of 15,759 AYA, the percentage of those who received a 6-month HIV viral load testing increased from 40.6% in 2017 to 64.7% in 2022 and, a notable annual increase of 5.6% (p < 0.001). A higher HIV viral load testing uptake was observed among 20- to 24-year-olds (87.7%) compared to 10- to 19-year-olds (80.2%) (p < 0.001). The likelihood of not receiving an HIV viral load test within 12 months of antiretroviral therapy initiation was higher among 10- to 19-year-olds (adjusted odds ratio [aOR] = 1.7; 95% confidence interval [CI] = 1.4-2.0), advanced HIV disease (aOR = 1.3; 95% CI = 1.12-1.53), normal nutrition status at enrolment aOR 2.6 (95% CI = 1.59-4.26) and initiation of non-nucleoside reverse transcriptase inhibitors regimen aOR 1.2 (95% CI = 1.08-1.34). The proportion of AYA with viral suppression increased from 83.0% in 2017 to 94.6% in 2022. Notably, the overall trend in viral suppression increased significantly at 2.4% annually. The risk of not achieving viral suppression was greater among 10- to 14-year-olds (aOR = 2; 95% CI = 1.75-2.43) and 15- to 19-year-olds (aOR = 1.4; 95% CI = 1.24-1.58) as compared to 20-24 years; being male (aOR = 1.16; 95% CI = 1.02-1.32); undernourished (aOR = 1.53; 95% CI = 1.17-1.99); in WHO Stage II (aOR = 1.16; 95% CI = 1.02-1.33) and III (aOR = 1.21; 95% CI = 1.03-1.42) and being on an non-nucleoside reverse transcriptase inhibitors regimen (aOR = 1.32; 95% CI = 1.18-1.48).
CONCLUSION
CONCLUSIONS
HIV viral load testing uptake at 6 months of antiretroviral therapy initiation and viral suppression increased from 2017 to 2022; however, overall HIV viral load testing was suboptimal. Demographic and clinical characteristics can be used to identify AYA at greater risk for not having HIV viral load test and not achieving viral suppression.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Training Tanzania Researchers for HIV/AIDS Implementation Science
ID : 43TW009775-01AI
Informations de copyright
© 2024 John Wiley & Sons Ltd.
Références
Amour MA, Shayo GA, Matee MM, Machumi L, Rugarabamu A, Aris EA, et al. Predictors of mortality among adolescents and young adults living with HIV on antiretroviral therapy in Dar es Salaam, Tanzania: a retrospective cohort study. J Int AIDS Soc. 2022;25(2):e25886.
Desta AA, Woldearegay TW, Futwi N, Gebrehiwot GT, Gebru GG, Berhe AA, et al. HIV virological non‐suppression and factors associated with non‐suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study. BMC Infect Dis. 2020;20(1):4.
Martelli G, Antonucci R, Mukurasi A, Zepherine H, Nöstlinger C. Adherence to antiretroviral treatment among children and adolescents in Tanzania: comparison between pill count and viral load outcomes in a rural context of Mwanza region. PLoS One. 2019;14(3):e0214014.
Muri L, Gamell A, Ntamatungiro AJ, Glass TR, Luwanda LB, Battegay M, et al. Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern. AIDS. 2017;31(1):61–70.
Marcus R, Ferrand RA, Kranzer K, Bekker LG. The case for viral load testing in adolescents in resource‐limited settings. J Int AIDS Soc. 2017;20(Suppl 7):e25002.
Pham MD, Nguyen HV, Anderson D, Crowe S, Luchters S. Viral load monitoring for people living with HIV in the era of test and treat: progress made and challenges ahead—a systematic review. BMC Public Health. 2022;22(1):1203.
Narainsamy D, Mahomed S. Delays in switching patients onto second‐line antiretroviral treatment at a public hospital in eThekwini, KwaZulu‐Natal. South Afr J HIV Med. 2017;18(1):696.
Lyatuu GW, Mwashemele SZ, Urrio R, Naburi H, Kashmir N, Machumi L, et al. Long‐term virological outcomes in women who started option B+ care during pregnancy for prevention of mother‐to‐child transmission of HIV in Dar es Salaam, Tanzania: a cohort study. Lancet HIV. 2021;8(5):e256–e265.
Badejo O, Noestlinger C, Jolayemi T, Adeola J, Okonkwo P, van Belle S, et al. Multilevel modelling and multiple group analysis of disparities in continuity of care and viral suppression among adolescents and youths living with HIV in Nigeria. BMJ Global Health. 2020;5(11):e003269.
Nakalega R, Mukiza N, Kiwanuka G, Makanga‐Kakumba R, Menge R, Kataike H, et al. Non‐uptake of viral load testing among people receiving HIV treatment in Gomba district, rural Uganda. BMC Infect Dis. 2020;20(1):727.
National AIDS Control Programme. p. 181. Available from: https://nacp.go.tz/download/national-guidelines-for-the-management-of-hiv-and-aids/
National AIDS Control Programme. National guidelines for the management of HIV and AIDS in Tanzania; 2019.
Ewetola R, Shah GH, Maluantesa L, Etheredge G, Waterfield K, Mulenga A, et al. Disparities in HIV clinical stages progression of patients at outpatient clinics in Democratic Republic of Congo. Int J Environ Res Public Health. 2021;18(10):5341.
Koletsi D, Pandis N. The chi‐square test for trend. Am J Orthod Dentofacial Orthop. 2016;150(6):1066–1067.
Chen B, Xu W. Generalized estimating equation modeling on correlated microbiome sequencing data with longitudinal measures. PLoS Comput Biol. 2020;16(9):e1008108.
Awungafac G, Amin ET, Fualefac A, Takah NF Lucy AA, Nwobegahay J, et al. Viral load testing and the use of test results for clinical decision making for HIV treatment in Cameroon: an insight into the clinic‐laboratory interface. PLoS One. 2018;13(6):e0198686.
Glass TR, Motaboli L, Nsakala B, Lerotholi M, Vanobberghen F, Amstutz A, et al. The viral load monitoring cascade in a resource‐limited setting: a prospective multicentre cohort study after introduction of routine viral load monitoring in rural Lesotho. PLoS One. 2019;14(8):e0220337.
Maulide Cane R, Melesse DY, Kayeyi N, Manu A, Wado YD, Barros A, et al. HIV trends and disparities by gender and urban‐rural residence among adolescents in sub‐Saharan Africa. Reprod Health. 2021;18(Suppl 1):120.
Roberts T, Cohn J, Bonner K, Hargreaves S. Scale‐up of routine viral load testing in resource‐poor settings: current and future implementation challenges. Clin Infect Dis. 2016;62(8):1043–1048.
Maskew M, Technau K, Davies MA, Vreeman R, Fox MP. Adolescent retention in HIV care within differentiated service‐delivery models in sub‐Saharan Africa. Lancet HIV. 2022;9(10):e726–e734.
Swannet S, Decroo T, de Castro SMTL, Rose C, Giuliani R, Molfino L, et al. Journey towards universal viral load monitoring in Maputo, Mozambique: many gaps, but encouraging signs. Int Health. 2017;9(4):206–214.
Zanoni BC, Archary M, Sibaya T, Musinguzi N, Haberer JE. Transition from pediatric to adult care for adolescents living with HIV in South Africa: a natural experiment and survival analysis. PLoS One. 2020;15(10):e0240918.
Mutagonda RF, Mlyuka HJ, Maganda BA, Kamuhabwa AA. Adherence, effectiveness and safety of dolutegravir based antiretroviral regimens among HIV infected children and adolescents in Tanzania. J Int Assoc Provid AIDS Care. 2022;21:23259582221109613.
vanWyk BE, Davids L‐AC. Challenges to HIV treatment adherence amongst adolescents in a low socio‐economic setting in Cape Town. South Afr J HIV Med. 2019;20(1):1002.
Parienti JJ, Fournier AL, Cotte L, Schneider MP, Etienne M, Unal G, et al. Forgiveness of dolutegravir‐based triple therapy compared with older antiretroviral regimens: a prospective multicenter cohort of adherence patterns and HIV‐RNA replication. Open Forum Infect Dis. 2021;8(7):ofab316.
Hailu GG, Hagos DG, Hagos AK, Wasihun AG, Dejene TA. Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia. PLoS One. 2018;13(5):e0196259.
Penot P, Héma A, Bado G, Kaboré F, Soré I, Sombié D, et al. The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso. J Int AIDS Soc. 2014;17(1):18646.
Haghighat R, Toska E, Bungane N, Cluver L. The HIV care cascade for adolescents initiated on antiretroviral therapy in a health district of South Africa: a retrospective cohort study. BMC Infect Dis. 2021;21(1):60.
Simms V, Bernays S, Chibanda D, Chinoda S, Mutsinze A, Beji‐Chauke R, et al. Risk factors for HIV virological non‐suppression among adolescents with common mental disorder symptoms in Zimbabwe: a cross‐sectional study. J Int AIDS Soc. 2021;24(8):e25773.